Answers are grounded in this paper and cite their sources.
In Pearson v. Shalala, the court restricts FDA authority by allowing sellers of dietary supplements to make health claims based on less than “significant scientific agreement” when these claims are accompanied by a disclaimer. The authors raise issues regarding the lack of standards for substantiation and the effectiveness of disclaimers in light of the untested nature of some supplements and the vulnerabilities of some supplement consumers.
No takes yet. Share an insight, caveat, or question.
Mason et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: